Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy.

Katherine S CoolsHanna K SanoffHong Jin KimJen Jen YehKaryn B Stitzenberg

Published in: Journal of surgical oncology (2018)

NAT does not increase the overall postoperative morbidity or mortality of PD for PDA. There is a decreased likelihood of pancreatic fistulas in patients that receive neoadjuvant therapy.

Keyphrases

rectal cancer
end stage renal disease
patients undergoing
lymph node
locally advanced
newly diagnosed
chronic kidney disease
prognostic factors
squamous cell carcinoma
cardiovascular events
coronary artery disease
patient reported outcomes
patient reported